Perseon Corporation (PRSN) - NASDAQ
  • Sep. 1, 2015, 4:06 PM
    • Perseon (NASDAQ:PRSN) CFO William Barth notifies the company that he will retire as soon as a successor is hired or effective December 31. He joined the firm in 2012.
    | Sep. 1, 2015, 4:06 PM
  • Jul. 30, 2015, 12:47 PM
    | Jul. 30, 2015, 12:47 PM | 7 Comments
  • Jul. 30, 2015, 10:02 AM
    • Thinly traded nano cap Perseon (PRSN -44%) plummets on a 6x surge in volume, albeit on turnover of only 181K, in response to the pricing of its public offering of 5.75M shares of common stock and warrants to purchase 11.5M shares of common stock at $0.99 per share. The price for each share plus two warrants is $0.90. Underwriters over-allotment is an additional 862.5K shares and 1.725M warrants. Closing date is August 4.
    • The warrants will begin trading trading today under the symbol "PRSNW."
    | Jul. 30, 2015, 10:02 AM | 1 Comment
  • Jul. 30, 2015, 9:12 AM
    | Jul. 30, 2015, 9:12 AM | 6 Comments
  • Jul. 22, 2015, 12:45 PM
    | Jul. 22, 2015, 12:45 PM | 10 Comments
  • Jul. 16, 2015, 10:03 AM
    • Perseon (PRSN +4.3%) Q2 results: Revenues: $1M (-16.7%); COGS: $0.3M (-57.1%); R&D Expense: $0.6M (-6.6%); SG&A: $2.9M (+45.0%); Operating Loss: ($2.8M) (-33.3%); Net Loss: ($2.9M) (-38.1%); Loss Per Share: ($0.72) (-14.3%); Quick Assets: $0.9M (-83.9%); CF Ops: ($5.4M) (-107.7%).
    • 2015 Guidance: Revenue: $3.5M - $5M.
    | Jul. 16, 2015, 10:03 AM
  • Jul. 16, 2015, 9:17 AM
    • Perseon (NASDAQ:PRSN): Q2 EPS of -$0.72
    • Revenue of $0.95M (-20.8% Y/Y)
    | Jul. 16, 2015, 9:17 AM
  • Jul. 13, 2015, 12:45 PM
    | Jul. 13, 2015, 12:45 PM | 3 Comments
  • Jun. 30, 2015, 12:47 PM
    | Jun. 30, 2015, 12:47 PM | 4 Comments
  • Jun. 22, 2015, 1:31 PM
    • Thinly traded nano cap Perseon (PRSN -8.3%) will execute a 1:10 reverse split of its common shares effective tomorrow. The number of outstanding shares after the split will be ~4M.
    | Jun. 22, 2015, 1:31 PM | 3 Comments
  • May 14, 2015, 10:08 AM
    • Perseon (PRSN -2%) Q1 results: Revenues: $1.2M (-20.0%); COGS: $0.8M (-11.1%); R&D Expense: $0.5M (-3.8%); SG&A: $2.7M (+58.8%); Net Loss: ($2.9M) (-81.3%); Loss Per Share: ($0.07) (-40.0%); Quick Assets: $3.6M (-35.7%); CF Ops: ($2.8M) (-154.5%).
    • No guidance given.
    | May 14, 2015, 10:08 AM
  • May 14, 2015, 9:26 AM
    • Perseon (NASDAQ:PRSN): Q1 EPS of -$0.07
    • Revenue of $1.16M (-24.7% Y/Y)
    | May 14, 2015, 9:26 AM | 1 Comment
  • Apr. 14, 2015, 11:18 AM
    • The FDA approves Perseon's (PRSN +8.9%) MicroThermX Microwave Ablation System for ablation procedures requiring partial or complete ablation of non-resectable liver tumors. It was cleared for laparoscopic ablation procedures using image guidance last week.
    • Perseon, formally known as BSD Medical, assumed its new corporate identity in February.
    | Apr. 14, 2015, 11:18 AM
  • Feb. 24, 2015, 4:59 PM
    • BSD Medical (NASDAQ:BSDM) changes its name to Perseon Corporation. The stock symbol will change to PRSN effective tomorrow.
    • The company's new website will go live in Q2.
    | Feb. 24, 2015, 4:59 PM | 1 Comment
  • Feb. 11, 2015, 12:40 PM
    • Thinly-traded nano cap BSD Medical (BSDM +27.8%) jumps on triple normal volume. Shares have more than doubled since the low of $0.19 on January 21.
    • Money flow has turned positive since new CEO Clint Carnell took over in November. On January 29, the company announced that it submitted a non-binding term sheet for the potential sale of its hyperthermia assets. The divestment is part of Mr. Carnell's strategy to concentrate the firm's resources on its microwave ablation technology.
    • On Monday, the firm announced the resignations of two board members. This will allow Mr. Carnell to recruit successors who have the knowledge and experience to help him successfully execute his growth plans.
    | Feb. 11, 2015, 12:40 PM | 2 Comments
  • Jan. 15, 2015, 9:42 AM
    • BSD Medical (BSDM -16.7%) FQ1 results: Revenues: $0.8M (-38.5%); COGS: $0.5M (-16.7%); Operating Expenses: $2.4M (+9.1%); Net Loss: ($2M) (-33.3%); Loss Per Share: ($0.05) (-25.0%); Quick Assets: $6.2M (-23.5%); CF Ops: ($1.9M) (-2.2%).
    • No guidance given.
    | Jan. 15, 2015, 9:42 AM
Company Description
Perseon Corp. develops, manufactures, markets and services medical systems that deliver precision-focused radio frequency or microwave energy into diseased sites of the body, heating them to specified temperatures as required by a variety of medical therapies. Its product line for cancer therapy... More
Sector: Healthcare
Industry: Medical Appliances & Equipment
Country: United States